Alabama Oncology, Bruno Cancer Center

Clinical research site in Birmingham, Alabama

As of July 2026, 1 paid clinical trial is recruiting at Alabama Oncology, Bruno Cancer Center in Birmingham, Alabama. Active studies at this site cover conditions such as Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic and Non-Small Cell Lung Carcinoma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Alabama Oncology, Bruno Cancer Center (1)

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

for Non-small Cell Carcinoma

133 locations incl. Alabaster

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07144280·Phase 3·Recruiting·Listed Aug 2025

Apply to this trial

More research sites in Birmingham

University of Alabama at Birmingham (331 trials)
Children's Hospital of Alabama (39 trials)
University of Alabama (33 trials)
University of Alabama at Birmingham Cancer Center (30 trials)
The University of Alabama at Birmingham (27 trials)
University of Alabama Birmingham (27 trials)
UAB (15 trials)
Children's of Alabama (15 trials)
University of Alabama Hospital (13 trials)
Birmingham VA Medical Center, Birmingham, AL (10 trials)

Explore more

Paid clinical trials in Birmingham, AL · Alabama clinical trials